• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

/ / Botox Treatment Technical Information

Botox Treatment Technical Information

16 May 2020 | 

Summary of Botox Technical Information

BOTOX (botulinum toxin type A) is a medicinal product used for various therapeutic indications. Here is a summary of the key information:

Composition and Formulation

BOTOX contains botulinum toxin type A from Clostridium botulinum. It is supplied as a powder for solution for injection, with 50 Allergan Units per vial. The powder appears as a thin white deposit that may be difficult to see. Excipients include human albumin and sodium chloride.

Therapeutic Indications

BOTOX is indicated for:

Dosage and Administration

Dosage varies by indication. Key points:

Contraindications

Warnings and Precautions

Adverse Effects

Common adverse effects include:

Pharmacodynamics

BOTOX blocks acetylcholine release at nerve terminals, causing localized chemical denervation. Effects typically onset within 1-2 weeks and last 3-4 months.

Clinical Efficacy

Efficacy demonstrated in clinical trials for all approved indications, with statistically significant improvements vs placebo in relevant endpoints.

Reconstitution and Handling

Storage

Store in refrigerator (2-8°C) or freezer (-5 to -20°C).This summary covers the essential information on BOTOX composition, indications, dosing, safety, efficacy, and handling. Healthcare professionals should refer to the full prescribing information for complete details before use.

This Botox Technical Information Is For Medical Professionals

1. Name of the medicinal product: 

50 Allergan Units

Powder for solution for injection

2. Qualitative and quantitative composition

Botulinum toxin* type A, 50 Allergan Units/vial.

* from Clostridium botulinum

Botulinum toxin units are not interchangeable from one product to another.

For a full list of excipients, see section 6.1.

3. Pharmaceutical form

Powder for solution for injection.

 product appears as a thin white deposit that may be difficult to see on the base of the vial.

4. Clinical particulars

4.1 Therapeutic indications

 is indicated for:

Neurologic disorders: